A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gastrointestinal Endoscopy - Volume 88, Issue 3, September 2018, Pages 427-437.e6

Douglas K. MD, Raj MD, Taddese MD, Michael P. MD, Cynthia MD, Kyle MD, Charles F. MD, Ronald MD, Brooks D. MD, Daniel MD, Felix MD, Shelby MD, David MD,